160 related articles for article (PubMed ID: 33047871)
1. Pterostilbene enhances sorafenib's anticancer effects on gastric adenocarcinoma.
Zhao T; Wang C; Huo X; He ML; Chen J
J Cell Mol Med; 2020 Nov; 24(21):12525-12536. PubMed ID: 33047871
[TBL] [Abstract][Full Text] [Related]
2. Low-dose taxotere enhances the ability of sorafenib to induce apoptosis in gastric cancer models.
Tesei A; Leonetti C; Zupi G; Scarsella M; Brigliadori G; Ulivi P; Fabbri F; Arienti C; Amadori D; Passardi A; Silvestrini R; Zoli W
J Cell Mol Med; 2011 Feb; 15(2):316-26. PubMed ID: 20015197
[TBL] [Abstract][Full Text] [Related]
3. AKR1B10 Inhibitor Epalrestat Facilitates Sorafenib-Induced Apoptosis and Autophagy Via Targeting the mTOR Pathway in Hepatocellular Carcinoma.
Geng N; Jin Y; Li Y; Zhu S; Bai H
Int J Med Sci; 2020; 17(9):1246-1256. PubMed ID: 32547320
[TBL] [Abstract][Full Text] [Related]
4. Pterostilbene exerts antitumor activity via the Notch1 signaling pathway in human lung adenocarcinoma cells.
Yang Y; Yan X; Duan W; Yan J; Yi W; Liang Z; Wang N; Li Y; Chen W; Yu S; Jin Z; Yi D
PLoS One; 2013; 8(5):e62652. PubMed ID: 23671619
[TBL] [Abstract][Full Text] [Related]
5. A novel multitarget kinase inhibitor BZG with potent anticancer activity in vitro and vivo enhances efficacy of sorafenib through PI3K pathways in hepatocellular carcinoma cells.
Wang L; Zhan Y; Wu Z; Lin M; Jin X; Jiang L; Qiu Y
Biomed Pharmacother; 2020 May; 125():110033. PubMed ID: 32187962
[TBL] [Abstract][Full Text] [Related]
6. Dichloroacetate enhances the anti-tumor effect of sorafenib via modulating the ROS-JNK-Mcl-1 pathway in liver cancer cells.
Sun L; Jiang Y; Yan X; Dai X; Huang C; Chen L; Li T; Zhang Y; Xiao H; Yang M; Xiang L; Zhang Y; Chen S; Li S; Chen A; He F; Lian J
Exp Cell Res; 2021 Sep; 406(1):112755. PubMed ID: 34332981
[TBL] [Abstract][Full Text] [Related]
7. The newly synthesized anticancer drug HUHS1015 is useful for treatment of human gastric cancer.
Kaku Y; Tsuchiya A; Kanno T; Nakao S; Shimizu T; Tanaka A; Nishizaki T
Cancer Chemother Pharmacol; 2015 Mar; 75(3):527-35. PubMed ID: 25567349
[TBL] [Abstract][Full Text] [Related]
8. Usnic Acid Induces Cycle Arrest, Apoptosis, and Autophagy in Gastric Cancer Cells In Vitro and In Vivo.
Geng X; Zhang X; Zhou B; Zhang C; Tu J; Chen X; Wang J; Gao H; Qin G; Pan W
Med Sci Monit; 2018 Jan; 24():556-566. PubMed ID: 29374767
[TBL] [Abstract][Full Text] [Related]
9. Dual PI3K/mTOR inhibitor BEZ235 exerts extensive antitumor activity in HER2-positive gastric cancer.
Zhu Y; Tian T; Zou J; Wang Q; Li Z; Li Y; Liu X; Dong B; Li N; Gao J; Shen L
BMC Cancer; 2015 Nov; 15():894. PubMed ID: 26560145
[TBL] [Abstract][Full Text] [Related]
10. Sorafenib inhibits 5-fluorouracil-resistant gastric cancer cell growth.
Kim HM; Kim SA; Park SB; Cho JH; Song SY
Scand J Gastroenterol; 2017 May; 52(5):577-584. PubMed ID: 28110575
[TBL] [Abstract][Full Text] [Related]
11. SoLAT (Sorafenib Lenvatinib alternating treatment): a new treatment protocol with alternating Sorafenib and Lenvatinib for refractory thyroid Cancer.
Kim SY; Kim SM; Chang HJ; Kim BW; Lee YS; Park CS; Park KC; Chang HS
BMC Cancer; 2018 Oct; 18(1):956. PubMed ID: 30286728
[TBL] [Abstract][Full Text] [Related]
12. Sensitizing gastric adenocarcinoma to chemotherapy by pharmacological manipulation of drug transporters.
Al-Abdulla R; Perez-Silva L; Lozano E; Macias RIR; Herraez E; Abad M; Segues N; Bujanda L; Briz O; Marin JJG
Biochem Pharmacol; 2020 Jan; 171():113682. PubMed ID: 31669256
[TBL] [Abstract][Full Text] [Related]
13. A novel combination of withaferin A and sorafenib shows synergistic efficacy against both papillary and anaplastic thyroid cancers.
Cohen SM; Mukerji R; Timmermann BN; Samadi AK; Cohen MS
Am J Surg; 2012 Dec; 204(6):895-900; discussion 900-1. PubMed ID: 23231932
[TBL] [Abstract][Full Text] [Related]
14. β-Cryptoxanthin induced anti-proliferation and apoptosis by G0/G1 arrest and AMPK signal inactivation in gastric cancer.
Gao M; Dang F; Deng C
Eur J Pharmacol; 2019 Sep; 859():172528. PubMed ID: 31288004
[TBL] [Abstract][Full Text] [Related]
15. Licoricidin inhibits the growth of SW480 human colorectal adenocarcinoma cells in vitro and in vivo by inducing cycle arrest, apoptosis and autophagy.
Ji S; Tang S; Li K; Li Z; Liang W; Qiao X; Wang Q; Yu S; Ye M
Toxicol Appl Pharmacol; 2017 Jul; 326():25-33. PubMed ID: 28416456
[TBL] [Abstract][Full Text] [Related]
16. Anti-tumor potential of 15,16-dihydrotanshinone I against breast adenocarcinoma through inducing G1 arrest and apoptosis.
Tsai SL; Suk FM; Wang CI; Liu DZ; Hou WC; Lin PJ; Hung LF; Liang YC
Biochem Pharmacol; 2007 Dec; 74(11):1575-86. PubMed ID: 17869226
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol inhibits the growth of gastric cancer by inducing G1 phase arrest and senescence in a Sirt1-dependent manner.
Yang Q; Wang B; Zang W; Wang X; Liu Z; Li W; Jia J
PLoS One; 2013; 8(11):e70627. PubMed ID: 24278101
[TBL] [Abstract][Full Text] [Related]
18. JD enhances the anti-tumour effects of low-dose paclitaxel on gastric cancer MKN45 cells both in vitro and in vivo.
Wang C; Wang R; Zhou K; Wang S; Wang J; Shi H; Dou Y; Yang D; Chang L; Shi X; Liu Y; Xu X; Zhang X; Ke Y; Liu H
Cancer Chemother Pharmacol; 2016 Nov; 78(5):971-982. PubMed ID: 27620208
[TBL] [Abstract][Full Text] [Related]
19. Tanshinone I induces apoptosis and pro-survival autophagy in gastric cancers.
Jing X; Xu Y; Cheng W; Guo S; Zou Y; He L
Cancer Chemother Pharmacol; 2016 Jun; 77(6):1171-81. PubMed ID: 27100736
[TBL] [Abstract][Full Text] [Related]
20. Combination therapy of sorafenib with mesenchymal stem cells as a novel cancer treatment regimen in xenograft models of hepatocellular carcinoma.
Seyhoun I; Hajighasemlou S; Muhammadnejad S; Ai J; Nikbakht M; Alizadeh AA; Hosseinzadeh F; Mirmoghtadaei M; Seyhoun SM; Verdi J
J Cell Physiol; 2019 Jun; 234(6):9495-9503. PubMed ID: 30362607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]